1. Home
  2. MXCT vs MG Comparison

MXCT vs MG Comparison

Compare MXCT & MG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MXCT
  • MG
  • Stock Information
  • Founded
  • MXCT 1999
  • MG 1978
  • Country
  • MXCT United States
  • MG United States
  • Employees
  • MXCT N/A
  • MG N/A
  • Industry
  • MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • MG Military/Government/Technical
  • Sector
  • MXCT Health Care
  • MG Consumer Discretionary
  • Exchange
  • MXCT Nasdaq
  • MG Nasdaq
  • Market Cap
  • MXCT 361.8M
  • MG 303.0M
  • IPO Year
  • MXCT 2021
  • MG 2009
  • Fundamental
  • Price
  • MXCT $2.71
  • MG $10.50
  • Analyst Decision
  • MXCT Strong Buy
  • MG Hold
  • Analyst Count
  • MXCT 2
  • MG 1
  • Target Price
  • MXCT $10.00
  • MG $11.00
  • AVG Volume (30 Days)
  • MXCT 701.5K
  • MG 209.7K
  • Earning Date
  • MXCT 03-11-2025
  • MG 03-05-2025
  • Dividend Yield
  • MXCT N/A
  • MG N/A
  • EPS Growth
  • MXCT N/A
  • MG N/A
  • EPS
  • MXCT N/A
  • MG 0.60
  • Revenue
  • MXCT $38,627,000.00
  • MG $729,640,000.00
  • Revenue This Year
  • MXCT $20.01
  • MG $5.79
  • Revenue Next Year
  • MXCT $26.64
  • MG $3.26
  • P/E Ratio
  • MXCT N/A
  • MG $17.47
  • Revenue Growth
  • MXCT N/A
  • MG 3.43
  • 52 Week Low
  • MXCT $2.62
  • MG $7.45
  • 52 Week High
  • MXCT $5.26
  • MG $12.44
  • Technical
  • Relative Strength Index (RSI)
  • MXCT 27.30
  • MG 56.08
  • Support Level
  • MXCT $2.62
  • MG $10.26
  • Resistance Level
  • MXCT $3.17
  • MG $10.95
  • Average True Range (ATR)
  • MXCT 0.17
  • MG 0.34
  • MACD
  • MXCT -0.02
  • MG 0.03
  • Stochastic Oscillator
  • MXCT 11.27
  • MG 65.27

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

About MG Mistras Group Inc

MISTRAS Group Inc provides asset protection solutions and systems. The company evaluates the structural integrity and reliability of critical energy, industrial, and public infrastructure. The company's three operating segments are North America, International and Products and Systems, of which key revenue is derived from the North America segment. Services segment provides asset protection solutions predominantly in North America, with the large amount of concentration in the United States, followed by Canada, consisting of non-destructive testing, and inspection. The asset protection solutions include field inspections, consulting, maintenance, data management, access, monitoring and laboratory quality assurance.

Share on Social Networks: